XML 30 R14.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT INFORMATION | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
SEGMENT INFORMATION | SEGMENT INFORMATION The Company has four operating segments, organized primarily by product, which are also the Company’s reportable segments. These are (i) Connected Technology Solutions, (ii) Essential Dental Solutions, (iii) Orthodontic and Implant Solutions, and (iv) Wellspect Healthcare. These operating segments are identified in accordance with how the Company’s chief operating decision maker (“CODM”) regularly reviews financial results and uses this information to evaluate the Company’s performance and allocate resources. The Company’s CODM is the Chief Executive Officer. The Company’s reportable segment information was as follows:
|  | Three Months Ended September 30, |
(in millions) |  | 2025 |  |  |
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total |  |  |
Net sales |  | $ | 259 |  |  | $ | 357 |  |  | $ | 205 |  |  | $ | 83 |  |  | $ | 904 |  |  |  |
Adjusted cost of products sold (a) |  | 157 |  |  | 140 |  |  | 95 |  |  | 33 |  |  |  |  |  |
Adjusted selling expenses (b) |  | 55 |  |  | 77 |  |  | 56 |  |  | 13 |  |  |  |  |  |
Adjusted G&A expenses (b) |  | 20 |  |  | 18 |  |  | 20 |  |  | 7 |  |  |  |  |  |
Adjusted R&D expenses (c) |  | 17 |  |  | 6 |  |  | 12 |  |  | 2 |  |  |  |  |  |
Segment adjusted operating income |  | $ | 10 |  |  | $ | 116 |  |  | $ | 22 |  |  | $ | 28 |  |  | $ | 176 |  |  |  |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 69 |  |  |  |
Interest expense, net |  |  |  |  |  |  |  |  |  | 23 |  |  |  |
Other income |  |  |  |  |  |  |  |  |  | (11) |  |  |  |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 262 |  |  |  |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 5 |  |  |  |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 57 |  |  |  |
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations |  |  |  |  |  |  |  |  |  | 1 |  |  |  |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (230) |  |  |  |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
|  | Three Months Ended September 30,
(in millions) |  | 2024
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total
Net sales |  | $ | 269 |  |  | $ | 369 |  |  | $ | 241 |  |  | $ | 72 |  |  | $ | 951 |
Adjusted cost of products sold (a) |  | 156 |  |  | 138 |  |  | 100 |  |  | 25 |  |  |
Adjusted selling expenses (b) |  | 60 |  |  | 76 |  |  | 75 |  |  | 12 |  |  |
Adjusted G&A expenses (b) |  | 19 |  |  | 17 |  |  | 29 |  |  | 7 |  |  |
Adjusted R&D expenses (c) |  | 18 |  |  | 6 |  |  | 13 |  |  | 2 |  |  |
Segment adjusted operating income |  | $ | 16 |  |  | $ | 132 |  |  | $ | 24 |  |  | $ | 26 |  |  | $ | 198 |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 79 |
Interest expense, net |  |  |  |  |  |  |  |  |  | 18 |
Other income |  |  |  |  |  |  |  |  |  | (2) |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 504 |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 23 |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 54 |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (478) |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
|  | Nine Months Ended September 30, |
(in millions) |  | 2025 |  |  |
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total |  |  |
Net sales |  | $ | 737 |  |  | $ | 1,097 |  |  | $ | 648 |  |  | $ | 237 |  |  | $ | 2,719 |  |  |  |
Adjusted cost of products sold (a) |  | 432 |  |  | 402 |  |  | 286 |  |  | 93 |  |  |  |  |  |
Adjusted selling expenses (b) |  | 167 |  |  | 220 |  |  | 164 |  |  | 39 |  |  |  |  |  |
Adjusted G&A expenses (b) |  | 58 |  |  | 55 |  |  | 59 |  |  | 20 |  |  |  |  |  |
Adjusted R&D expenses (c) |  | 51 |  |  | 17 |  |  | 35 |  |  | 7 |  |  |  |  |  |
Segment adjusted operating income |  | $ | 29 |  |  | $ | 403 |  |  | $ | 104 |  |  | $ | 78 |  |  | $ | 614 |  |  |  |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 224 |  |  |  |
Interest expense, net |  |  |  |  |  |  |  |  |  | 66 |  |  |  |
Other income |  |  |  |  |  |  |  |  |  | (10) |  |  |  |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 497 |  |  |  |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 18 |  |  |  |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 156 |  |  |  |
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations |  |  |  |  |  |  |  |  |  | 2 |  |  |  |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (339) |  |  |  |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
|  | Nine Months Ended September 30,
(in millions) |  | 2024
|  | Connected Technology Solutions |  | Essential Dental Solutions |  | Orthodontic and Implant Solutions |  | Wellspect Healthcare |  | Total
Net sales |  | $ | 769 |  |  | $ | 1,108 |  |  | $ | 788 |  |  | $ | 223 |  |  | $ | 2,888 |
Adjusted cost of products sold (a) |  | 452 |  |  | 424 |  |  | 307 |  |  | 83 |  |  |
Adjusted selling expenses (b) |  | 183 |  |  | 239 |  |  | 238 |  |  | 39 |  |  |
Adjusted G&A expenses (b) |  | 57 |  |  | 56 |  |  | 96 |  |  | 21 |  |  |
Adjusted R&D expenses (c) |  | 56 |  |  | 17 |  |  | 39 |  |  | 7 |  |  |
Segment adjusted operating income |  | $ | 21 |  |  | $ | 372 |  |  | $ | 108 |  |  | $ | 73 |  |  | $ | 574 |
Reconciling items (income) expense: |  |  |  |  |  |  |  |  |  |
Unallocated corporate costs (d) |  |  |  |  |  |  |  |  |  | $ | 227 |
Interest expense, net |  |  |  |  |  |  |  |  |  | 53 |
Other income |  |  |  |  |  |  |  |  |  | (10) |
Goodwill and intangible asset impairments |  |  |  |  |  |  |  |  |  | 510 |
Restructuring and other costs |  |  |  |  |  |  |  |  |  | 45 |
Amortization of intangibles |  |  |  |  |  |  |  |  |  | 162 |
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (413) |
(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.
(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.
(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.
(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment.
Depreciation and Amortization
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(in millions) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Connected Technology Solutions |  | 48 |  | 44 |  |  | 137 |  | 130
Essential Dental Solutions |  | 9 |  | 9 |  |  | 26 |  | 26
Orthodontic and Implant Solutions |  | 24 |  | 25 |  |  | 66 |  | 75
Wellspect Healthcare |  | 5 |  | 5 |  |  | 13 |  | 14
All other (a) |  | 6 |  | 6 |  |  | 17 |  | 16
Total |  | 92 |  | 89 |  |  | 259 |  | 261
(a) Includes unallocated corporate costs for depreciation and amortization.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration